Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RTIL 13 is a highly effective inhibitor of dynamin GTPase, exhibiting an IC50 value of 2.3 μM for dynamin I GTPase. Furthermore, it selectively interacts with the pleckstrin homology lipid binding domain. This compound effectively suppresses both receptor-mediated and synaptic vesicle endocytosis, demonstrating IC50 values of 9.3 μM and 7.1 μM, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | RTIL 13 is a highly effective inhibitor of dynamin GTPase, exhibiting an IC50 value of 2.3 μM for dynamin I GTPase. Furthermore, it selectively interacts with the pleckstrin homology lipid binding domain. This compound effectively suppresses both receptor-mediated and synaptic vesicle endocytosis, demonstrating IC50 values of 9.3 μM and 7.1 μM, respectively. |
Targets&IC50 | Dynamin I GTPase:2.3 µM (IC50) |
In vitro | RTIL 13 effectively inhibits receptor-mediated and synaptic vesicle endocytosis, demonstrating inhibition concentrations (IC50s) of 9.3 μM and 7.1 μM, respectively[2]. |
Molecular Weight | 571.685 |
Formula | C30H55BrN2O3 |
CAS No. | 1009376-10-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RTIL 13 1009376-10-6 RTIL13 RTIL-13 inhibitor inhibit